Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Volasertib Combined With Standard Induction Chemotherapy for Previously Untreated Patients With Acute Myeloid Leukemia (VIAC)

NCT02527174 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT02527174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02527174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Volasertib Combined With Standard Induction Chemotherapy for Previously Untreated Patients With Acute Myeloid Leukemia (VIAC)
Lead sponsor
University of Alberta
Phase
Phase 1
Overall status
Withdrawn
Start date
November 30, 2016
Completion date
September 30, 2018
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, erythroblastic, acute, leukemia, megakaryoblastic, acute, leukemia, monocytic, acute, leukemia, myeloid, acute, leukemia, myelomonocytic, acute